CalciMedica, Inc. is trading at $0.99, up 11.1% in after-hours trading as the stock attracts bargain hunters following a 4% decline during the regular session.
- The move follows a period where a recent rebound lost momentum, with shares now benefiting from broader risk-on sentiment.
- No new regulatory filings, press releases, or analyst updates have been issued, suggesting the price action is driven by normal volatility in a thinly traded small-cap biotech name.